EVP Sales and Marketing, Richard Bertran Promoted to President of SurgiCount Medical

Tuesday, January 24, 2006, 9:00 am ET

Medical Product Sales Veteran Bertran to Help Lead Roll Out of Safety-Sponge™ System in 2006

SANTA MONICA, Calif., Jan 24, 2006 (BUSINESS WIRE) -- Patient Safety Technologies, Inc. (AMEX:PST - News) announced today that Rick Bertran has been promoted to President of its wholly-owned subsidiary, SurgiCount Medical, Inc.  Mr. Bertran served prior as SurgiCount’s Executive Vice President of Global Sales and Marketing, bringing over 15 years of surgical product and technology sales and marketing experience to SurgiCount.  Mr. Bertran will help in the roll out of the company’s patented Safety-Sponge™ System, as it readies for distribution into U.S. hospitals currently scheduled for this spring.*

“Mr. Bertran’s proven track record, tireless efforts and dedication have paved the way for his promotion to the newly created President role, which has gone unfilled until now,” said Louis Glazer, MD, Patient Safety Technologies’ Chairman and CEO. Mr. Bertran has had a distinguished career, most recently as Director of North American Sales for eNGENUITY Technology, a global leader in visualization and simulation software for the aerospace, defense, and automotive industries.  From 1988 to 1998, Mr. Bertran served as Western Regional Sales Manager for Maxxim Medical, an industry leader in the creation and packaging of custom surgical packs.  In his last fiscal year with Maxxim, Mr. Bertran produced in excess of $40,000,000 in sales, an increase of 12% from the previous year, and was consistently one of the top three regions out of ten in sales, gross profit and percent to quota.“I am extremely excited about the opportunities and future of SurgiCount Medical and the patented technologies behind the Safety-Sponge System,” stated Rick Bertran.  “We have a real opportunity to positively impact and improve upon the patient care environment.”About Patient Safety Technologies, Inc.Patient Safety Technologies, Inc. (PST) is a holding company that owns assets in various businesses. Its wholly-owned subsidiary, SurgiCount Medical, Inc., is a developer and manufacturer of patient safety products and services. SurgiCount concentrates on surgical safety to support its patient safety device, the Safety-Sponge™ System. The Safety-Sponge System helps in reducing the number of retained sponges and towels in patients during surgical procedures and allows for faster and more accurate counting of surgical sponges. For more information on Patient Safety Technologies, Inc., please contact the company directly at 310-895-7750, or by email at info@patientsafetytechnologies.com or http://www.patientsafetytechnologies.com. FORWARD-LOOKING STATEMENTS This press release contains certain forward-looking statements. These forward-looking statements can generally be identified as such because the context of the statement will include words such as Patient Safety Technologies “plans”, "expects," "should," "believes," "anticipates" or words of similar import. Stockholders, potential investors and other readers are cautioned that these forward-looking statements are predictions based only on current information and expectations that are inherently subject to risks and uncertainties that could cause future events or results to differ materially from those set forth or implied by the forward-looking statements. Certain of those risks and uncertainties are discussed in our filings with the Securities and Exchange Commission, including our annual report on Form 10-K and quarterly reports on Form 10-Q. These forward-looking statements are only made as of the date of this press release and Patient Safety Technologies does not undertake any obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances. * Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including factors that could delay, divert or change any of them, and could cause actual outcomes and results to differ materially from current expectations. No forward-looking statement can be guaranteed.